Kronos Bio Inc. (NASDAQ: KRON) Stock Information | RedChip

Kronos Bio Inc. (NASDAQ: KRON) Listen to this Section


$1.00
+0.0124 ( +1.26% ) 100.3K

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Market Data


Open


$1.00

Previous close


$0.99

Volume


100.3K

Market cap


$60.26M

Day range


$0.97 - $1.01

52 week range


$0.69 - $1.62

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 74 Nov 13, 2023
8-k 8K-related 12 Nov 02, 2023
8-k 8K-related 13 Oct 05, 2023
3 Insider transactions 2 Sep 18, 2023
8-k 8K-related 12 Sep 18, 2023
8-k 8K-related 12 Aug 17, 2023
10-q Quarterly Reports 69 Aug 08, 2023
8-k 8K-related 14 Aug 08, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.